XDH and metabolic dysfunction-associated steatotic liver disease: Several human studies found a high activity of serum xanthine oxidoreductase in NAFLD patients, which catalyzes formation of uric acid, and then the increased generation of uric acid is able to accelerate the development of NAFLD mediated by xanthine oxidoreductase [6].